Sorry, you need to enable JavaScript to visit this website.

Featured Stories

Purpose & Ideals

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Science & Innovation

Behind the Science: Breaking the Cycle of C. difficile

The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.

Real People

'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care

Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.

Press Releases

Categories

Keywords

  • All Keywords

September 2017

August 2017

Resource Library

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits Details
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Contact Pfizer Media Relations

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]